Neuronetics Reports Fourth Quarter and Full Year 2020 Financial and Operating ResultsGlobeNewsWire • 03/02/21
Neuronetics (STIM) Soars 6.5%: Is Further Upside Left in the Stock?Zacks Investment Research • 03/02/21
Neuronetics to Report Fourth Quarter and Fiscal Year 2020 Financial and Operating Results and Host Conference CallGlobeNewsWire • 02/16/21
Neuronetics to Participate at the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostic Tools ConferenceGlobeNewsWire • 02/10/21
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2020 Financial ResultsGlobeNewsWire • 01/12/21
Neuronetics Announces the Amendment of Credit Facility with Solar Capital PartnersGlobeNewsWire • 12/08/20
Neuronetics to Participate in the Piper Sandler 32nd Annual Virtual Healthcare ConferenceGlobeNewsWire • 11/30/20
Neuronetics® Receives FDA Clearance for Three-Minute TouchStar™ Treatment ProtocolGlobeNewsWire • 11/23/20
Neuronetics to Present at the Canaccord Genuity Virtual MedTech & Diagnostics ForumGlobeNewsWire • 11/12/20
Neuronetics, Inc. (STIM) CEO Keith Sullivan on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha • 11/03/20
Neuronetics to Report Third Quarter 2020 Financial and Operating Results and Host Conference CallGlobeNewsWire • 10/19/20
NeuroStar® Advanced Therapy Providers Offer Free TMS Consultations During National Depression Awareness MonthGlobeNewsWire • 10/01/20
Neuronetics Unveils New Depression Data at Clinical TMS Society’s Virtual EventsGlobeNewsWire • 09/22/20
Neuronetics, Inc. (STIM) CEO Keith Sullivan on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/08/20